Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients

Anca Daniela Farcaş1,2, Florin Petru Anton1,2, Cerasela Mihaela Goidescu1,2

  • 1"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Disease Markers
|June 2, 2017
PubMed

Insights

Serum ST2 levels can help detect cardiac remodeling and diastolic dysfunction in hypertension. This biomarker offers valuable insights beyond traditional echocardiography for early detection of heart performance changes.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Hypertension Management

Background:

  • Echocardiography has limitations in assessing hypertensive left ventricular (LV) changes.
  • Serum ST2, a known prognostic biomarker, is understudied in hypertension.

Purpose of the Study:

  • To investigate the association between serum ST2 levels and diastolic dysfunction (DD) in hypertensive patients.
  • To explore ST2 as a potential biomarker for cardiac remodeling in hypertension.

Main Methods:

  • Prospective study of 88 hypertensive outpatients (mean age 65).
  • Stratification based on left ventricular hypertrophy (LVH).
  • Clinical examination, routine lab work, serum ST2 measurement, and echocardiography were performed.

Main Results:

  • Patients with LVH showed higher age, blood pressure, and serum ST2 levels.
  • Serum ST2 levels correlated significantly with LV remodeling and DD parameters.
  • Identified cut-off values for discriminating LVH and diastolic dysfunction grades.

Conclusions:

  • ST2 shows potential as a diagnostic biomarker for cardiac remodeling and diastolic dysfunction in hypertension.
  • ST2 can supplement echocardiography, aiding in the early detection of cardiac performance alterations.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
688
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
657
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
787
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
1.8K